Brief: Biocartis Gets EUR 1.4 Mln Grant For New Idylla Technology
May 11 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* BIOCARTIS RECEIVES EUR 1.4M GRANT TO SUPPORT DEVELOPMENT
OF NEW
IDYLLA™ TECHNOLOGY TO UNLOCK POTENTIAL IN MOLECULAR SURVEILLANCE
* BIOCARTIS EXPECTS TO LAUNCH FIRST IDYLLA™ PRODUCTS THAT
MAKE USE
OF THIS NEW IDYLLA™ TECHNOLOGY IN COURSE OF 2022
Source text for Eikon: ID:nGNE6nfp3f
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies